Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;99(5):1145-1149.
doi: 10.4269/ajtmh.18-0509.

Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014

Jessica T Lin  1 , Jaymin C Patel  2 , Lauren Levitz  2 , Mariusz Wojnarski  3 , Suwanna Chaorattanakawee  4 , Panita Gosi  3 , Nillawan Buathong  3 , Soklyda Chann  5 , Rekol Huy  6 , Khengheng Thay  6 , Darapiseth Sea  5 , Nou Samon  5 , Shannon Takala-Harrison  7 , Mark Fukuda  3 , Philip Smith  3 , Michele Spring  3 , David Saunders  8 , Chanthap Lon  5
Affiliations

Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014

Jessica T Lin et al. Am J Trop Med Hyg. 2018 Nov.

Abstract

Gametocytes are the malaria parasite stages responsible for transmission from humans to mosquitoes. Gametocytemia often follows drug treatment, especially as therapies start to fail. We examined Plasmodium falciparum gametocyte carriage and drug resistance profiles among 824 persons with uncomplicated malaria in Cambodia to determine whether prevalent drug resistance and antimalarial use has led to a concentration of drug-resistant parasites among gametocyte carriers. Although report of prior antimalarial use increased from 2008 to 2014, the prevalence of study participants presenting with microscopic gametocyte carriage declined. Gametocytemia was more common in those reporting antimalarial use within the past year, and prior antimalarial use was correlated with higher IC50s to piperaquine and mefloquine, as well as to increased pfmdr1 copy number. However, there was no association between microscopic gametocyte carriage and parasite drug resistance. Thus, we found no evidence that the infectious reservoir, marked by those carrying gametocytes, is enriched with drug-resistant parasites.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Gametocyte prevalence (A) and reported antimalarial use (B and C) in persons presenting with uncomplicated falciparum malaria in Cambodia from 2008 to 2014. Gametocyte prevalence (gray bars) refers to the proportion of study participants with gametocytemia detected by microscopy at enrollment. Antimalarial use denotes reported usage over the previous 12-month (recent antimalarial use in the preceding 7 days (WR1576) or 28–30 days (WR1877 and WR1396 were exclusion criteria). Artemisinin-based combination therapies (ACTs) reported included dihydroartemisinin–piperaquine or artesunate–mefloquine combinations, and non-ACT use was predominantly chloroquine for vivax malaria. Artesunate and artemether were included with ACTs, whereas antimalarial use reported as unknown is denoted as missing data.
Figure 2.
Figure 2.
Relationship of antimalarial use within the past year (A) and gametocyte carriage (B) to drug resistance profiles based on ex vivo IC50s and molecular markers of resistance. Red lines mark threshold for classifying parasites as resistant based on WHO-defined cutoffs (chloroquine and mefloquine) or the upper quartile for piperaquine resistance. This figure appears in color at www.ajtmh.org.
See this image and copyright information in PMC

References

    1. WHO , 2013. Emergency Response to Artemisinin Resistance in the Greater Mekong Subregion Regional framework for action 2013–2015. World Health Organization Archived publication. Available at: http://www.who.int/malaria/publications/atoz/9789241505321/en/. Accessed February 4, 2018.
    1. Chaorattanakawee S, et al. 2015. Ex vivo drug susceptibility testing and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia from 2008 to 2013 suggest emerging piperaquine resistance. Antimicrob Agents Chemother 59: 4631–4643. - PMC - PubMed
    1. Spring MD, et al. 2015. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis 15: 683–691. - PubMed
    1. Lon CT, Tsuyuoka R, Phanouvong S, Nivanna N, Socheat D, Sokhan C, Blum N, Christophel EM, Smine A, 2006. Counterfeit and substandard antimalarial drugs in Cambodia. Trans R Soc Trop Med Hyg 100: 1019–1024. - PubMed
    1. Bousema T, Drakeley C, 2011. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24: 377–410. - PMC - PubMed

Publication types

LinkOut - more resources